Letter: Maintenance therapy in myeloma: risk versus benefit.
D002330:Carmustine / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced; D008558:Melphalan / Q000009:adverse effects / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use
D008558:Melphalan; D002330:Carmustine; D011241:Prednisone